v3.26.1
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2024
Sep. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance $ (7,185,574)   $ (12,183,292) $ (22,902,000) $ (18,160,646) $ (40,630,758) $ 3,412,459 $ 3,412,459 $ 3,412,459 $ (22,902,000) $ 3,412,459
Net Income (Loss) (1,430,668)     9,194,630 (9,717,896) 21,914,426 (32,535,982) (10,621,556) (20,339,452) (41,004,000) (32,417,033)
Balance (8,268,588)     (12,183,292) (18,786,644) (18,160,646) (40,630,758) (18,160,646) (18,786,644) (7,185,574) (22,902,000)
Shares issued from exercise of Series B Warrants         2,299,253 104,024          
Shares issued from exercise of Series A Warrants       241,546 193,757         4,475,854 7,323,195
Additional Paid-in Capital [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance 159,027,646 $ 103,738,980 103,535,931 101,998,956 82,483,948   28,850,985 28,850,985 28,850,985 101,998,956 28,850,985
Net Income (Loss)      
Balance 159,453,519 104,518,211 103,738,980 103,535,931 93,968,741 82,483,948   82,483,948 93,968,741 159,027,646 101,998,956
Shares issued from exercise of Series B Warrants         2,298,737 104,004          
Shares issued from exercise of Series A Warrants       241,472 193,710         4,475,753 7,321,820
Retained Earnings [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance (163,372,539) (115,287,768) (113,173,909) (122,368,539) (100,573,062)   (25,445,506) (25,445,506) (25,445,506) (122,368,539) (25,445,506)
Net Income (Loss) (1,430,668) (4,092,145) (2,113,859) 9,194,630 (9,717,896) 21,914,426       (41,004,000) (32,417,033)
Balance (164,803,207) (119,379,913) (115,287,768) (113,173,909) (110,290,958) (100,573,062)   (100,573,062) (110,290,958) (163,372,539) (122,368,539)
Shares issued from exercise of Series B Warrants                  
Shares issued from exercise of Series A Warrants              
Stock Subscription Receivable [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance (2,841,427) (2,545,586) (2,545,586) (2,545,586) (80,241)   (2,545,586)
Net Income (Loss)      
Balance $ (2,919,674) $ (2,545,586) $ (2,545,586) (2,545,586) (2,476,160) (80,241)   (80,241) (2,476,160) (2,841,427) (2,545,586)
Shares issued from exercise of Series B Warrants                  
Shares issued from exercise of Series A Warrants              
As Previously Reported [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       (22,902,000) (18,160,646) (40,630,758) 3,412,459 3,412,459 3,412,459 (22,902,000) 3,412,459
Convertible note – stock issuance loss                    
Net Income (Loss)         (6,636,679) 22,018,416 (29,766,263)       (25,929,003)
Balance         (18,786,644) (18,160,646) (40,630,758) (18,160,646) (18,786,644)   (22,902,000)
Shares issued from exercise of Series B Warrants         1,886 34         1,959
Shares issued from exercise of Series A Warrants         162,054           4,257,282
Issuance of common stock for Forward Purchase Agreement                  
Forward Purchase Agreement – subscription receivable discount                  
As Previously Reported [Member] | Additional Paid-in Capital [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       93,045,581 79,610,239 79,158,563 28,850,985 28,850,985 28,850,985 93,045,581 28,850,985
Convertible note – stock issuance loss                    
Net Income (Loss)              
Balance         85,617,896 79,610,239 79,158,563 79,610,239 85,617,896   93,045,581
Shares issued from exercise of Series B Warrants         1,370 14         1,384
Shares issued from exercise of Series A Warrants         162,007           4,255,907
Issuance of common stock for Forward Purchase Agreement         (954)           (954)
Forward Purchase Agreement – subscription receivable discount                  
As Previously Reported [Member] | Retained Earnings [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       (115,880,509) (97,699,353) (119,717,769) (25,445,506) (25,445,506) (25,445,506) (115,880,509) (25,445,506)
Convertible note – stock issuance loss                    
Net Income (Loss)         (6,636,679) 22,018,416 (29,766,263)       (25,929,003)
Balance         (104,336,032) (97,699,353) (119,717,769) (97,699,353) (104,336,032)   (115,880,509)
Shares issued from exercise of Series B Warrants                
Shares issued from exercise of Series A Warrants                  
Issuance of common stock for Forward Purchase Agreement                  
Forward Purchase Agreement – subscription receivable discount                  
As Previously Reported [Member] | Stock Subscription Receivable [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       (80,241) (80,241) (80,241) (80,241)
Convertible note – stock issuance loss                    
Net Income (Loss)              
Balance         (80,241) (80,241) (80,241) (80,241) (80,241)   (80,241)
Shares issued from exercise of Series B Warrants                
Shares issued from exercise of Series A Warrants                  
Issuance of common stock for Forward Purchase Agreement                  
Forward Purchase Agreement – subscription receivable discount                  
Revision of Prior Period, Adjustment [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance      
Convertible note – stock issuance loss             2,769,719        
Net Income (Loss)         (3,081,217) (103,990) (2,769,719) (2,873,709) (5,954,926)   (6,488,030)
Balance          
Shares issued from exercise of Series B Warrants         2,297,367 103,990         2,669,970
Shares issued from exercise of Series A Warrants         31,703           3,065,913
Issuance of common stock for Forward Purchase Agreement         752,147           752,147
Forward Purchase Agreement – subscription receivable discount                    
Revision of Prior Period, Adjustment [Member] | Additional Paid-in Capital [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       8,953,375 103,990 2,769,719 8,953,375
Convertible note – stock issuance loss             2,769,719        
Net Income (Loss)              
Balance         5,477,136 103,990 2,769,719 103,990 5,477,136   8,953,375
Shares issued from exercise of Series B Warrants         2,297,367 103,990         2,669,970
Shares issued from exercise of Series A Warrants         31,703           3,065,913
Issuance of common stock for Forward Purchase Agreement         3,124,379           3,124,379
Forward Purchase Agreement – subscription receivable discount         23,687           93,113
Revision of Prior Period, Adjustment [Member] | Retained Earnings [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       (6,488,030) (103,990) (2,769,719) (6,488,030)
Convertible note – stock issuance loss                    
Net Income (Loss)         (3,081,217) (103,990) (2,769,719)       (6,488,030)
Balance         (3,081,217) (103,990) (2,769,719) (103,990) (3,081,217)   (6,488,030)
Shares issued from exercise of Series B Warrants                
Shares issued from exercise of Series A Warrants                  
Issuance of common stock for Forward Purchase Agreement                  
Forward Purchase Agreement – subscription receivable discount                    
Revision of Prior Period, Adjustment [Member] | Stock Subscription Receivable [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       (2,465,345) (2,465,345)
Convertible note – stock issuance loss                    
Net Income (Loss)              
Balance         (2,395,919) (2,395,919)   (2,465,345)
Shares issued from exercise of Series B Warrants                
Shares issued from exercise of Series A Warrants                  
Issuance of common stock for Forward Purchase Agreement         (2,372,232)           (2,372,232)
Forward Purchase Agreement – subscription receivable discount         (23,687)           (93,113)
Retroactive Application of Recapitalization [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       (22,902,000) (18,160,646) (40,630,758) 3,412,459 3,412,459 3,412,459 (22,902,000) 3,412,459
Convertible note – stock issuance loss             2,769,719        
Net Income (Loss)           21,914,426 (32,535,982)       (32,417,033)
Balance           (18,160,646) (40,630,758) (18,160,646)     (22,902,000)
Shares issued from exercise of Series B Warrants           104,024         2,671,929
Shares issued from exercise of Series A Warrants                     7,323,195
Retroactive Application of Recapitalization [Member] | Additional Paid-in Capital [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       101,998,956 82,483,948 81,928,282 28,850,985 28,850,985 28,850,985 101,998,956 28,850,985
Convertible note – stock issuance loss             2,769,719        
Net Income (Loss)                
Balance           82,483,948 81,928,282 82,483,948     101,998,956
Shares issued from exercise of Series B Warrants           104,004         2,671,354
Shares issued from exercise of Series A Warrants                     7,321,820
Retroactive Application of Recapitalization [Member] | Retained Earnings [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       (122,368,539) (100,573,062) (122,487,488) (25,445,506) (25,445,506) (25,445,506) (122,368,539) (25,445,506)
Convertible note – stock issuance loss                    
Net Income (Loss)           21,914,426 (32,535,982)       (32,417,033)
Balance           (100,573,062) (122,487,488) (100,573,062)     (122,368,539)
Shares issued from exercise of Series B Warrants                  
Shares issued from exercise of Series A Warrants                    
Retroactive Application of Recapitalization [Member] | Stock Subscription Receivable [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance       $ (2,545,586)   $ (80,241) $ (2,545,586)
Convertible note – stock issuance loss                    
Net Income (Loss)                  
Balance             (80,241)       (2,545,586)
Shares issued from exercise of Series B Warrants                    
Shares issued from exercise of Series A Warrants                    
Retroactive Application of Recapitalization [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance              
Issuance of common stock for Forward Purchase Agreement         752,147           752,147
Forward Purchase Agreement – subscription receivable discount                  
Retroactive Application of Recapitalization [Member] | Additional Paid-in Capital [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance             (6,980) (6,980) (6,980)   (6,980)
Issuance of common stock for Forward Purchase Agreement         3,123,425           3,123,425
Forward Purchase Agreement – subscription receivable discount         23,687           93,113
Retroactive Application of Recapitalization [Member] | Retained Earnings [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance              
Issuance of common stock for Forward Purchase Agreement                  
Forward Purchase Agreement – subscription receivable discount                  
Retroactive Application of Recapitalization [Member] | Stock Subscription Receivable [Member]                      
Correction of Errors in Previously Reported Consolidated Financial Statements - Schedule of Previously Reported Condensed Consolidated and Combined Statement of Changes in Stockholders’ (Deficit) Equity (Details) [Line Items]                      
Balance              
Issuance of common stock for Forward Purchase Agreement         (2,372,232)           (2,372,232)
Forward Purchase Agreement – subscription receivable discount         $ (23,687)           $ (93,113)